Elizabeth Wood, 26, was recommended semaglutide by her doctor to lower her BMI, and it's been "life-changing," Wood said
Oral tirzepatide is a daily pill that acts as a dual agonist for both the GLP-1 and GIP receptors, mimicking the bodys natural incretin hormones to enhance insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite
Tirzepatide, a dual GLP-1 and GIP receptor agonist, works differently in every personwhich is why starting with the smallest effective dose matters
human safety data remain limited
Hunger often comes back before the behavioral and emotional patterns that supported change on the medication have had time to become fully stable
This establishes the peptide as a potent agent within the central and peripheral nervous systems, capable of modulating key neurotransmitter systems and facilitating recovery from injury